Astellas Pharma Inc (OTC Pink - Limited Information:ALPMF)
| 11.81 Delayed Data As of Dec 05 |  +0.031 / +0.26%Today’s Change | 11.56 Today|||52-Week Range 17.00 | -24.17% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | 2019 | |||
| Revenue and Income | Net Revenues | 11.4B | 12.1B | 11.7B | 11.8B | |
| Cost of Goods Sold | 2.6B | 2.7B | 2.4B | 2.4B | ||
| Depreciation And Amortization | 576.2M | 589.1M | 585.2M | 572.2M | ||
| Operating Expenses | Gross Income | 8.3B | 8.8B | 8.8B | 8.8B | |
| General Expenses | 6.0B | 6.3B | 6.3B | 6.3B | ||
| Research And Development | 1.9B | 1.9B | 2.0B | 1.9B | ||
| Total Operating Expenses | 9.2B | 9.6B | 9.3B | 9.3B | ||
| Non-Operating Expenses | Operating Income | 2.3B | 2.6B | 2.4B | 2.5B | |
| Extraordinary Credit | -- | -- | 72.4M | 0.00 | ||
| Extraordinary Charge | -189.3M | -252.7M | -470.5M | -396.9M | ||
| Pre-Tax Equity Earnings | -- | -17.2M | -21.8M | -14.7M | ||
| Interest Expense On Debt | 10.5M | 12.3M | 11.8M | 11.7M | ||
| Equity In Earnings | -10.4M | -- | -- | -- | ||
| Other Expenses | 118.2M | 321.7M | -62.5M | 118.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 2.2B | 2.6B | 2.0B | 2.2B | |
| Income Taxes | -567.0M | -582.4M | -482.1M | -240.8M | ||
| Net Income | 1.6B | 2.0B | 1.5B | 2.0B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.2B | 2.1B | 2.0B | 1.9B | |
| Shares To Calculate EPS Diluted | 2.2B | 2.1B | 2.0B | 1.9B | ||
| Earnings Per Share | EPS | $0.75 | $0.96 | $0.73 | $1.04 | |
| EPS Diluted | $0.75 | $0.96 | $0.73 | $1.04 | ||
